Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.
作者信息
Bauchau Vincent, Bollaerts Kaatje, Bryan Phil, Buttery Jim, Davis Kourtney, Chen Robert T, Feikin Daniel R, Fretta Antonella, Frise Sarah, Gandhi-Banga Sonja, Izurieta Hector S, Jouquelet-Royer Corinne, Khromava Alena, Li Lin, Long Raj, MacDonald Sarah, Marcelon Lydie, Massouh Robert, Meeraus Wilhelmine, Munoz Flor M, Naim Karen, Nordenberg Dale, Nohynek Hanna, Rubino Heather, Salmon Daniel A, Sellers Sarah, Serradell Laurence, Torcel-Pagnon Laurence, Wilkins Jamie
机构信息
Independent, Previously GSK, Vaccine Safety, Wavre, Belgium.
P95 (Epidemiology and Pharmacovigilance Consultant and Services), Leuven (Flemish Brabant), Belgium.
出版信息
Drug Saf. 2025 May;48(5):577-585. doi: 10.1007/s40264-024-01510-9. Epub 2025 Jan 10.
Abstract
摘要
相似文献
1
Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.疫苗上市后监测未来的多利益相关方行动呼吁：首届超越COVID-19监测卓越（BeCOME）会议纪要
Drug Saf. 2025 May;48(5):577-585. doi: 10.1007/s40264-024-01510-9. Epub 2025 Jan 10.
2
Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.在欧洲，疫苗上市后公共-私营合作治理指南。
Vaccine. 2019 May 31;37(25):3278-3289. doi: 10.1016/j.vaccine.2019.04.073. Epub 2019 May 6.
3
Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities.真实世界监测 COVID-19 疫苗：行业专家视角下的成功经验、挑战与未来机遇。
Drug Saf. 2023 Apr;46(4):327-333. doi: 10.1007/s40264-023-01290-8. Epub 2023 Apr 11.
4
Marketing the COVID-19 vaccine and the implications for public health.新冠疫苗的市场营销及其对公共卫生的影响。
Vaccine. 2021 Aug 9;39(34):4766-4768. doi: 10.1016/j.vaccine.2021.07.015. Epub 2021 Jul 13.
5
Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines.为什么我们需要在欧洲加强合作以增强疫苗上市后监测。
Vaccine. 2020 Dec 22;38 Suppl 2:B1-B7. doi: 10.1016/j.vaccine.2019.07.081. Epub 2019 Oct 31.
6
Proceedings of the Online Conference "Vaccines and Vaccination during and Post COVID Pandemics" (7-9 December 2022).“新冠疫情期间及之后的疫苗与接种”在线会议论文集（2022年12月7 - 9日）
Vaccines (Basel). 2023 Jun 29;11(7):1175. doi: 10.3390/vaccines11071175.
7
Proceedings of the 2017 Advancing the Science of Community Engaged Research (CEnR) Conference.2017年社区参与研究（CEnR）科学进展会议论文集
BMC Proc. 2019 Apr 19;13(Suppl 3):3. doi: 10.1186/s12919-019-0164-y. eCollection 2019.
8
Social marketing interventions to increase HIV/STI testing uptake among men who have sex with men and male-to-female transgender women.旨在提高男男性行为者和男变女跨性别女性中艾滋病毒/性传播感染检测率的社会营销干预措施。
Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD009337. doi: 10.1002/14651858.CD009337.
9
Proceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care.神经治疗研讨会关于神经急症的会议记录：塑造神经危重症护理的未来。
Neurocrit Care. 2020 Dec;33(3):636-645. doi: 10.1007/s12028-020-01085-0. Epub 2020 Sep 21.
10
Using the '4Ps' social marketing strategy to overcome vaccination hesitancy: COVID-19 vaccine coverage in a Chinese college as an example.利用“4Ps”社会营销策略克服疫苗犹豫：以中国一所大学的 COVID-19 疫苗接种率为例。
Saudi Med J. 2023 Jun;44(6):560-596. doi: 10.15537/smj.2023.44.6.20220696.
引用本文的文献
1
De-risking vaccine development: lessons, challenges, and prospects.降低疫苗研发风险：经验教训、挑战与前景。
NPJ Vaccines. 2025 Jul 30;10(1):177. doi: 10.1038/s41541-025-01211-z.
本文引用的文献
1
Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities.真实世界监测 COVID-19 疫苗：行业专家视角下的成功经验、挑战与未来机遇。
Drug Saf. 2023 Apr;46(4):327-333. doi: 10.1007/s40264-023-01290-8. Epub 2023 Apr 11.
2
The v-safe after vaccination health checker: Active vaccine safety monitoring during CDC's COVID-19 pandemic response.v-safe 疫苗接种后健康状况监测：美国疾病预防控制中心应对 COVID-19 大流行期间的主动疫苗安全监测。
Vaccine. 2023 Feb 10;41(7):1310-1318. doi: 10.1016/j.vaccine.2022.12.031. Epub 2023 Jan 23.
3
The value of public-private collaborative real-world evidence platforms to monitor vaccine performance post authorization: DRIVE - a European initiative.授权后监测疫苗性能的公私合作真实世界证据平台的价值：DRIVE-一项欧洲倡议。
Expert Rev Vaccines. 2022 Dec;21(12):1701-1710. doi: 10.1080/14760584.2022.2137144. Epub 2022 Oct 27.
4
Guidance for the governance of public-private collaborations in vaccine post-marketing settings in Europe.在欧洲，疫苗上市后公共-私营合作治理指南。
Vaccine. 2019 May 31;37(25):3278-3289. doi: 10.1016/j.vaccine.2019.04.073. Epub 2019 May 6.
5
The ADVANCE Code of Conduct for collaborative vaccine studies.合作疫苗研究的ADVANCE行为准则。
Vaccine. 2017 Apr 4;35(15):1844-1855. doi: 10.1016/j.vaccine.2017.02.039. Epub 2017 Mar 9.
6
International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.国际合作评估甲型 H1N1 流感 2009 单价疫苗接种后吉兰-巴雷综合征的风险。
Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.
7
Success of program linking data sources to monitor H1N1 vaccine safety points to potential for even broader safety surveillance.项目成功将数据源链接起来以监测 H1N1 疫苗安全性，这表明更广泛的安全性监测具有潜力。
Health Aff (Millwood). 2012 Nov;31(11):2518-27. doi: 10.1377/hlthaff.2012.0104.
8
Enhancing vaccine safety surveillance: a capture-recapture analysis of intussusception after rotavirus vaccination.加强疫苗安全性监测：轮状病毒疫苗接种后肠套叠的捕获-再捕获分析
Am J Epidemiol. 2001 Dec 1;154(11):1006-12. doi: 10.1093/aje/154.11.1006.
Zotero 插件